Publication 7/21/2018 Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome. Greig JA, Nordin JML, Draper C, McMenamin D, Chroscinski EA, Bell P, Gray JT, Richman LK, Wilson JM Molecular Therapy Methods And Clinical Development
Publication 2/16/2018 AAV8 Gene Therapy Rescues the Newborn Phenotype of a Mouse Model of Crigler-Najjar. Greig JA, Nordin JML, Draper C, Bell P, Wilson JM Human Gene Therapy
